IGC Pharma, Inc. (IGC) › Net IncomeIGC Pharma, Inc. (IGC) — Net IncomeAnnual figures by fiscal year, from SEC filings.2011: -$20.24M2012: -$7.75M2013: -$2.25M2014: -$3.02M2015: -$4.61M2016: -$2.81M2017: -$1.87M2018: -$1.79M2019: -$4.10M2020: -$7.32M2021: -$8.81M2022: -$15.02M2023: -$11.51M2024: -$13.00M2025: -$7.12M-$7.12M2011Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$7.12M+45.2%2024-$13.00M-13.0%2023-$11.51M+23.4%2022-$15.02M-70.4%2021-$8.81M-20.5%2020-$7.32M-78.5%2019-$4.10M-129.4%2018-$1.79M+4.4%2017-$1.87M+33.5%2016-$2.81M+39.1%2015-$4.61M-52.7%2014-$3.02M-34.2%2013-$2.25M+70.9%2012-$7.75M+61.7%2011-$20.24M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share